Takeda Pharmaceutical Co Ltd World Conference on Lung Cancer (WCLC) Investor Call Transcript
And now, please welcome Director Investor Relations, Elizabeth Borgeson.
Thanks. Good evening, everyone. Thanks for joining us on our mobo call today. This is Elizabeth Borgeson. I'm a part of the Takeda Investor Relations team working out in New York City.
Before we get started, let me cover the safe harbor statement on the next slide. I'd like to remind everyone that we'll be discussing forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those discussed today. The factors that could cause our actual results to differ materially are discussed in the most recent Form 20-F and in our other SEC filings. Please also refer to the important notice on Page 2 of the presentation.
Next slide, please. All right. And without further ado, I'd like to introduce Teresa Bitetti. Teresa is the President of our Global Oncology Business Unit. Take it away, Teresa.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
